Trugenomix Health Inc
Trugenomix Health Inc, operating under the name Polaris Genomics, is dedicated to revolutionizing the assessment, diagnosis, and treatment of mental health and neuropsychiatric conditions through the integration of genomics and machine learning. Their ADAPT Neuropsychiatric Biomarker Discovery Platform combines targeted gene panels with advanced analytics to facilitate the development of biomarker-based diagnostics and therapeutics, ultimately aiming to enhance drug development and clinical tools in the mental health landscape.
By focusing on biological markers, Polaris Genomics seeks to improve the efficacy and accuracy of treatments, enabling individualized approaches that address underlying conditions rather than merely alleviating symptoms. The company actively collaborates with various stakeholders in the pharmaceutical, academic, clinical, and governmental sectors to advance research and clinical insights in mental health care.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.